Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more - 2The Best 10 Innovation Advancements of the Year
- 3Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- 4Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 5I’m a neuroscientist who taught rats to drive − their joy suggests how anticipating fun can enrich human life
- US EPA will reassess safety of herbicide paraquat, says its chief
- Vote In favor of Your Favored Cereal
- Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
- Grass Care Administrations for a Wonderful, Sound Yard
- Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
- Addiction-stricken community struggles to keep a syringe program going after Trump's order
- How a niche Catholic approach to infertility treatment became a new talking point for MAHA conservatives
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
